Literature DB >> 3942913

Von Hippel-Lindau disease in a Newfoundland kindred.

J S Green, M I Bowmer, G J Johnson.   

Abstract

Von Hippel-Lindau disease, an autosomal dominant condition with complete penetrance, has been recognized in a large family that originated in Newfoundland but has some members who live in New Brunswick and Ontario. A collaborative investigation was begun in 1982 to document the number of affected members and the extent of their disease and to improve management of the disease. The condition has been documented in 38 members of the family, 28 living and 10 dead. The most common manifestations are retinal angioma (present in 60% of the gene carriers) and pheochromocytoma (present in 53%). Of the 28 living affected members 14 had been identified before the study began. Only 3 of the 14 patients in whom the disease was subsequently diagnosed presented with symptoms; in the remaining 11 the condition was detected by routine screening. Overall the mean age at the time of diagnosis was 23 years; in the 21 affected members of the fourth generation it was 18 years. The authors outline a regimen of regular screening for members at risk that has evolved as a result of their experience with this family.

Entities:  

Mesh:

Year:  1986        PMID: 3942913      PMCID: PMC1490656     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  11 in total

1.  Pheochromocytoma; its relationship to the neurocutaneous syndromes.

Authors:  A S GLUSHIEN; M M MANSUY; D S LITTMAN
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

2.  Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members.

Authors:  W A Horton; V Wong; R Eldridge
Journal:  Arch Intern Med       Date:  1976-07

3.  Von Hippel-Lindau's disease: a report of five cases.

Authors:  Y M Rho
Journal:  Can Med Assoc J       Date:  1969-08-09       Impact factor: 8.262

4.  Pheochromocytoma and von Hippel-Lindau's disease.

Authors:  B A Lowden; G S Harris
Journal:  Can J Ophthalmol       Date:  1976-10       Impact factor: 1.882

5.  von Hippel-Lindau disease: a familial, often lethal, multi-system phakomatosis.

Authors:  P Hardwig; D M Robertson
Journal:  Ophthalmology       Date:  1984-03       Impact factor: 12.079

6.  Diagnosis and management of asymptomatic renal cell carcinomas in von Hippel-Lindau syndrome.

Authors:  E Levine; J W Weigel; D L Collins
Journal:  Urology       Date:  1983-02       Impact factor: 2.649

7.  Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family.

Authors:  N O Atuk; T McDonald; T Wood; J T Carpenter; M P Walzak; M Donaldson; J Y Gillenwater
Journal:  Medicine (Baltimore)       Date:  1979-05       Impact factor: 1.889

8.  CT screening of the abdomen in von Hippel-Lindau disease.

Authors:  E Levine; D L Collins; W A Horton; R N Schimke
Journal:  AJR Am J Roentgenol       Date:  1982-09       Impact factor: 3.959

9.  Segregation and linkage analyses of von Hippel Lindau disease among 220 descendants from one kindred.

Authors:  R C Go; J M Lamiell; Y E Hsia; J W Yuen; Y Paik
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

10.  Some important radiological aspects of the kidney in Hippel-Lindau syndrome: the value of prospective study in an affected family.

Authors:  K R Lee; E Wulfsberg; J J Kepes
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

View more
  14 in total

1.  Updating genograms in the practice of preventive medicine.

Authors:  P W Allderdice; E O'Leary; S Ficken
Journal:  Can Fam Physician       Date:  1988-04       Impact factor: 3.275

2.  Cerebellar hemangioblastoma associated with diffuse neonatal hemangiomatosis in an infant.

Authors:  Turkan Patiroglu; Dilek Sarici; Ekrem Unal; Ali Yikilmaz; Bulent Tucer; Musa Karakukcu; Mehmet Akif Ozdemir; Ozlem Canoz; Mustafa Akcakus
Journal:  Childs Nerv Syst       Date:  2012-07-22       Impact factor: 1.475

3.  Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.

Authors:  G M Glenn; L N Daniel; P Choyke; W M Linehan; E Oldfield; M B Gorin; S Hosoe; F Latif; G Weiss; M Walther
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

4.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Authors:  B R Seizinger; D I Smith; M R Filling-Katz; H Neumann; J S Green; P L Choyke; K M Anderson; R N Freiman; S M Klauck; J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 5.  Von Hippel-Lindau disease: a single gene, several hereditary tumors.

Authors:  J Crespigio; L C L Berbel; M A Dias; R F Berbel; S S Pereira; D Pignatelli; T L Mazzuco
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

6.  Von Hippel-Lindau disease complicated by acute pancreatitis and Evan's syndrome.

Authors:  S Tenner; A Roston; D Lichtenstein; G Sica; D Carr-Locke; P A Banks
Journal:  Int J Pancreatol       Date:  1995-12

7.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

8.  Central nervous system lesions in von Hippel-Lindau syndrome.

Authors:  H P Neumann; H R Eggert; R Scheremet; M Schumacher; M Mohadjer; A K Wakhloo; B Volk; U Hettmannsperger; P Riegler; P Schollmeyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

9.  Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene.

Authors:  F M Richards; E R Maher; F Latif; M E Phipps; K Tory; M Lush; P A Crossey; B Oostra; P Enblad; K H Gustavson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

10.  Pancreatic involvement in Korean patients with von Hippel-Lindau disease.

Authors:  Kwang Hyuck Lee; Jae Seung Lee; Bum Jin Kim; Jong Kyun Lee; Seong Hyun Kim; Seung Hoon Kim; Kyu Taek Lee
Journal:  J Gastroenterol       Date:  2009-03-31       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.